BDBM237379 US10052306, 195::rac-(3aR,5r,6aS)-2-(2- hydroxy-2-(4- hydroxyphenyl)ethyl)-5- (3-methoxy- benzyl)octahydro- cyclopenta[c]pyrrol-5-ol

SMILES COc1cccc(C[C@@]2(O)C[C@@H]3CN(CC(O)c4ccc(O)cc4)C[C@@H]3C2)c1

InChI Key InChIKey=BTYYADDXXRKSGN-ZZJXRCGISA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237379   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237379(US10052306, 195 | rac-(3aR,5r,6aS)-2-(2- hydroxy-2...)
Affinity DataIC50:  28.7nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent